Trials / Unknown
UnknownNCT00415987
Hematopoietic Stem Cell Transplantation in Myeloma
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Azienda Ospedaliera San Giovanni Battista · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The treatment assignment is based on the presence or absence of an HLA-identical sibling donor (Genetic Randomisation, NOT formal Randomisation). Patients with suitable HLA-identical sibling donors are offered a tandem transplant approach consisting of standard autografting nonmyeloablative radiotherapy and allografting. Patients without HLA-identical siblings are treated with standard double autologous transplantation as per Institutional guidelines or enrolled in other treatment programs approved by local IRBs.This is a multi-center study. The Division of Hematology of University of Torino at the S.G.B. Hospital, Torino, Italy, is the co-ordinating Center.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Hematopoietic Stem Cell Transplantation |
Timeline
- Completion
- 2006-09-01
- First posted
- 2006-12-27
- Last updated
- 2008-06-20
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00415987. Inclusion in this directory is not an endorsement.